SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-033269
Filing Date
2021-06-17
Accepted
2021-06-17 08:13:39
Documents
12
Period of Report
2021-06-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vor-8k_20210615.htm 8-K 59769
2 EX-10.1 vor-ex101_8.htm EX-10.1 152730
3 EX-10.2 vor-ex102_7.htm EX-10.2 236515
4 EX-99.1 vor-ex991_6.htm EX-99.1 13193
5 GRAPHIC ggzs1iy0bpjn000003.jpg GRAPHIC 169373
6 GRAPHIC gqn5vlx1jz5g000002.jpg GRAPHIC 3178
7 GRAPHIC gqn5vlx1jz5g000001.jpg GRAPHIC 3178
8 GRAPHIC g202evc1vbxk000001.jpg GRAPHIC 130906
9 GRAPHIC ggzs1iy0bpjn000001.jpg GRAPHIC 195298
10 GRAPHIC gyxfofhl41vt000001.jpg GRAPHIC 35641
11 GRAPHIC ggzs1iy0bpjn000002.jpg GRAPHIC 137604
12 GRAPHIC g202evc1vbxk000002.jpg GRAPHIC 162892
  Complete submission text file 0001564590-21-033269.txt   1618655
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 211023396
SIC: 2836 Biological Products, (No Diagnostic Substances)